相关实验视频
Updated: Jun 28, 2025

06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
586
预测糖尿病患者心力衰竭的方法
Alexander E Berezin1, Tetiana A Berezina2, Uta C Hoppe1
1Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria.
Expert review of endocrinology & metabolism
|April 16, 2024
概括
2型糖尿病 (T2DM) 显著预测心力衰竭 (HF). 先进的成像和新型生物标志物可以改善T2DM患者中HF预防的风险分层.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 2型糖尿病 (T2DM) 是心血管疾病的主要风险因素,也是新发性心力衰竭 (HF) 的强有力的预测因素.
- 有效的风险分层对于预防糖尿病患者的HF至关重要.
研究的目的:
- 审查关于成像预测因子和循环生物标志物的文献,以优化T2DM患者的HF预防策略.
- 评估常规和替代生物标志物的实用性,以确定该人群中的HF风险.
主要方法:
- 文献综述侧重于回声心脏学参数 (例如全球纵向菌株) 和循环生物标志物.
- 在T2DM和肥胖中分析既定和新生物标志物的诊断和预测值.
主要成果:
- 心声学参数和心脏代谢特征表明,对T2DM中HF风险分层有希望.
- 传统的生物标志物可能在肥胖的T2DM患者中不理想;针对纤维化,炎症和脂肪组织功能障碍的替代生物标志物是有希望的.
- 在临床呈现的HF中,尿素仍然很重要,但在T2DM中可能需要辅助标记物.
结论:
- 在T2DM患者中确定的HF风险识别需要常规生物标志物监测.
- 替代生物标志物方法显示出改善多种心血管和代谢风险因素的T2DM患者临床结果的潜力.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Heart Failure Drugs: Inotropic Agents
577
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
577
Diabetes: Symptoms, Diagnosis, and Complications
528
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
528

